Market Tracker

06/24 5:16pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.591
Delayed Data
As of Jun 24
 -0.0675 / -10.25%
Today’s Change
0.58
Today|||52-Week Range
2.50
-55.56%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.66
Today’s open0.64
Day’s range0.59 - 0.64
Volume13,049,633
Average volume (3 months)807,733
Market cap$92.0M
Dividend yield--
Data as of 4:02pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...-0.01-3.66%
XENEXenon Pharmaceutical...+0.06+0.96%
OCXOncoCyte Corp-0.16-4.30%
CORICorium International...+0.06+1.50%
Data as of 4:03pm ET, 06/24/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer
Jed Andrew Latkin
Chief Scientific Officer &
Senior Vice President
Frederick O. Cope
Corporate headquarters
Dublin, Ohio

Forecasts